Top Banner
ONCOLOGY AND PAIN MANAGEMENT WITH AN OCCUPATIONAL THERAPY FOCUS Jennifer Beall, Pharm.D. Assistant Professor, McWhorter School of Pharmacy Samford University
26

Oncology Lecture.ppt

Dec 17, 2014

Download

Documents

terrybear11

 
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Oncology Lecture.ppt

ONCOLOGY AND PAIN MANAGEMENT WITH AN OCCUPATIONAL THERAPY

FOCUSJennifer Beall, Pharm.D.Assistant Professor, McWhorter School of PharmacySamford University

Page 2: Oncology Lecture.ppt

Objectives

Describe and apply the basic principles of pharmacology to the drugs discussed

Identify the implications for occupational therapy evaluation and treatment

Describe the disease process of osteosarcoma, its treatment, and their impact on occupational therapy evaluation and treatment.

Page 3: Oncology Lecture.ppt

CHEMOTHERAPY: BACKGROUND

Most chemotherapy agents work by stopping growth of or killing cancer cells.

Biological process involved include cell cycle, RNA and DNA synthesis.

Newer cancer treatments attack cells from different ways: cutting off blood supply, identifying cancer cell as foreign, etc.

Page 4: Oncology Lecture.ppt

CHEMOTHERAPY: CELL CYCLE

G0: resting phase G1: pre-DNA synthesis S: DNA synthesis G2: post-DNA synthesis M: mitosis (actual cell division) Some chemotherapy drugs are cell-cycle-

specific

Page 5: Oncology Lecture.ppt

CHEMOTHERAPY: CONCEPTS

Growth fraction: percent of dividing cells related to total population of cancer cells

Total cell kill: every tumor cell that is able to divide must be killed to eliminate the cancer

Other factors also affect a cell’s response to chemo: tumor-cell heterogeneity, drug resistance, dose intensity and patient-specific factors.

Page 6: Oncology Lecture.ppt

CHEMOTHERAPY: SIDE EFFECTS

Most common: bone marrow toxicity, GI upset, alopecia

Some adverse effects are due to attack of rapidly-dividing cells

Neurotoxicity possible with several drugs (see appendix)

Page 7: Oncology Lecture.ppt

CHEMOTHERAPY: CATEGORIES

Alkylating Agents Antimetabolites Antibiotics Plant Alkaloids Hormones Heavy Metal Compounds Miscellaneous Agents

Page 8: Oncology Lecture.ppt

OSTEOSARCOMA

Osteosarcoma is cancer of bone that occurs mainly in adolescents and young adults

Surgery alone is not enough; patients will likely need chemotherapy

The site of the tumor can determine prognosis

Source:http://www.cancer.gov/cancerinfo/pdq/treatment/osteosarcoma/healthprofessional/#Section_1

Page 9: Oncology Lecture.ppt

OSTEOSARCOMA (Cont’d)

Chemotherapy regimens use methotrexate, doxorubicin, cyclophosphamide, cisplatin, ifosfamide, etoposide and carboplatin

Surgery and radiation therapy can also be used

Page 10: Oncology Lecture.ppt

ANALGESIA: BACKGROUND

Physiology of pain: – Stimulus activates nociceptors, which translates

stimulus into an electrical signal– Electrical signal is sent along the nerves to the

spinal cord– Pain is regulated in the CNS by opioid receptors

Page 11: Oncology Lecture.ppt

ANALGESIA: TREATMENT

WHO Analgesic ladder Non-opioids include acetaminophen

(Tylenol®), NSAIDs, COX-2 inhibitors Combination products include Darvocet,

Lortab, Vioden, Vicoprofen, Percocet Opioids include morphine, meperidine,

codeine, oxycodone, hydrocodone

Page 12: Oncology Lecture.ppt

ANALGESICS: NSAIDs

Mechanism of action: inhibits cyclooxygenase, which stops prostaglandin and thromboxane synthesis

Role of prostaglandins: ranges from vasodilation or –constriction, involved in inflammatory response, help produce fever, involved in dysmenorrhea

Role of thromboxane: blood clotting

Page 13: Oncology Lecture.ppt

ANALGESICS: NSAIDs

COX-1 vs. COX-2: – COX-1 is found in stomach mucosa, kidneys– Role of COX-1: helps protect stomach lining from

gastric acid; helps maintain renal function; helps regulate normal platelet activity

– COX-2 is produced by cells when they are injured– Role of COX-2: helps produce prostaglandins to

respond to pain and inflammation

Page 14: Oncology Lecture.ppt

ANALGESICS: USES OF NSAIDs

Treatment of pain / inflammation: these drugs are used for mild-moderate pain (i.e. muscle aches, arthritis, dysmenorrhea, post-surgical pain)

Treatment of fever: ibuprofen is most common; aspirin should NOT be used in children with fever

Page 15: Oncology Lecture.ppt

ANALGESICS: USES OF NSAIDs

Treatment of vascular disorders: aspirin is commonly used for its inhibition of platelet aggregation to prevent MI or stroke

Prevention of cancer: aspirin use may decrease risk of colon cancer; COX-2 inhibitors are being studied in preventing various types of cancer (skin, breast, colon)

Page 16: Oncology Lecture.ppt

ANALGESICS: NSAID SIDE EFFECTS

GI problems:– Ranges from discomfort to ulceration – May be prevented by using buffered or enteric-

coated formulations

Kidney problems– Especially in those with renal dysfunction or the

elderly

Page 17: Oncology Lecture.ppt

ANALGESICS: NSAID SIDE EFFECTS

Allergic-type reactions– Rare; produces bronchospasm, urticaria

Overdose– Aspirin: symptoms range from tinnitus to

metabolic acidosis– Acetaminophen: can result in liver failure

Page 18: Oncology Lecture.ppt

ANALGESICS: COX-2 INHIBITORS

Products on market: celecoxib (Celebrex®), rofecoxib (Vioxx®), meloxicam (Mobic®), valdecoxib (Bextra®)

Selective for COX-2 enzyme to reduce effects to GI tract, kidneys

May still cause GI side effects (diarrhea, heartburn); may increase risk of upper respiratory tract infections

Page 19: Oncology Lecture.ppt

ANALGESICS: ACETAMINOPHEN

Mechanism of action unknown; possibly via prostaglandin inhibition

Is analgesic and antipyretic; is not anti-inflammatory or anticoagulant

May be toxic to liver, especially when used with alcohol

Page 20: Oncology Lecture.ppt

ANALGESICS: OPIOIDS

“Opioid” vs. “narcotic” Endogenous opioid receptors:

– Mu: causes sedation, respiratory depression, constipation

– Kappa: causes sedation, psychotic effects, constipation

– Delta: inhibits dopamine release

Page 21: Oncology Lecture.ppt

ANALGESICS: OPIOIDS

Agonists: acts primarily at mu receptors

Agonist-antagonists: act as agonists at one type of receptor yet acts as antagonist at other types

Antagonists: block opioid receptors

Page 22: Oncology Lecture.ppt

ANALGESICS: OPIOIDS

Mechanism of action: inhibition of transmission of the electrical signal across the synapse.

Opioid receptors are located on pre-and post-synaptic neurons

Decreases neurotransmitter release from presynaptic neuron; decreases excitability of postsynaptic neuron

Page 23: Oncology Lecture.ppt

ANALGESICS: OPIOIDS

Clinical applications:– Used mostly for severe and chronic pain– Strengths: no maximum dose, effective, available

in several dosage forms (including PCA)– Weaknesses: side effects (sedation, constipation,

respiratory depression), potential for abuse and addiction

Page 24: Oncology Lecture.ppt

ANALGESICS: OPIOIDS

Addiction: psychological dependence, seen as continued need for drug for effects other than pain relief

Tolerance: a larger dose is required to maintain the original effect

Physical dependence: patient experience withdrawal symptoms if drug is suddenly discontinued

Page 25: Oncology Lecture.ppt

CONCLUSION: SPECIAL CONCERNS FOR REHABILITATION PATIENTS

Chemotherapy:– Drugs that can cause neurotoxic effects– Cancers that affect bone, or nervous system

Analgesia:– Drugs used to treat disorders requiring

rehabilitation– Side effects of opioids (i.e. sedation, dizziness)

that require special handling of patients

Page 26: Oncology Lecture.ppt

QUESTIONS?